Cargando…

Differential expression of circulating miRNAs after alemtuzumab induction therapy in lung transplantation

Alemtuzumab is a monoclonal antibody targeting CD52, used as induction therapy after lung transplantation (LTx). Its engagement produces a long-lasting immunodepletion; however, the mechanisms driving cell reconstitution are poorly defined. We hypothesized that miRNAs are involved in this process. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benazzo, A., Bozzini, S., Auner, S., Berezhinskiy, H. Oya, Watzenboeck, M. L., Schwarz, S., Schweiger, T., Klepetko, W., Wekerle, T., Hoetzenecker, K., Meloni, F., Jaksch, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056512/ https://www.ncbi.nlm.nih.gov/pubmed/35490174 http://dx.doi.org/10.1038/s41598-022-10866-w

Ejemplares similares

Mechanisms of Action of Extracorporeal Photopheresis in the Control of Bronchiolitis Obliterans Syndrome (BOS): Involvement of Circulating miRNAs
por: Bozzini, Sara, et al.
Publicado: (2022)

Combined low-dose everolimus and low-dose tacrolimus after Alemtuzumab induction therapy: a randomized prospective trial in lung transplantation
por: Benazzo, Alberto, et al.
Publicado: (2021)

Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: A single centre experience
por: Benazzo, Alberto, et al.
Publicado: (2019)

Gamma-Glutamyltransferase at the Time of Listing May Predict Irreversible Severe Cholangiopathy After Lung Transplantation for COVID19-ARDS
por: Schwarz, S., et al.
Publicado: (2022)

Impact of Prone Positioning after Lung Transplantation - A Single Center Experience
por: Frick, A.E., et al.
Publicado: (2021)

Simultaneous pectus excavatum correction and lung transplantation–A case series
por: Rahimi, Nina, et al.
Publicado: (2020)

Comparison of donor scores in bilateral lung transplantation—A large single‐center analysis
por: Schwarz, Stefan, et al.
Publicado: (2020)

Alemtuzumab induction in pediatric kidney transplantation
por: Kaabak, Michael M, et al.
Publicado: (2013)

MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction
por: Miyahara, Naofumi, et al.
Publicado: (2022)

Alemtuzumab induction therapy in solid organ transplantation
por: Friend, Peter J
Publicado: (2013)

Outcome of lung transplantation in cystic fibrosis patients with severe asymmetric chest cavities
por: Sinn, Katharina, et al.
Publicado: (2021)

Prioritizing direct heart procurement in organ donors after circulatory death does not jeopardize lung transplant outcomes
por: Schwarz, Stefan, et al.
Publicado: (2022)

Outcome reporting in laryngotracheal surgery: we need functional analysis!
por: Schweiger, Thomas, et al.
Publicado: (2020)

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
por: Furukawa, Masashi, et al.
Publicado: (2022)

Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients
por: Bank, Jonna R., et al.
Publicado: (2016)

Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
por: Guthoff, Martina, et al.
Publicado: (2020)

The Effect of Prone Positioning After Lung Transplantation
por: Frick, Anna Elisabeth, et al.
Publicado: (2023)

Lung transplantation for acute respiratory distress syndrome: A multicenter experience
por: Frick, Anna E., et al.
Publicado: (2021)

Alemtuzumab
por: Tridente, Giuseppe
Publicado: (2013)

Comparison of the Effect of Alemtuzumab versus Standard Immune Induction on Early Kidney Allograft Function in Shiraz Transplant Center
por: Khalafi-Nezhad, A., et al.
Publicado: (2015)

Pre-Transplant Plasma Torque Teno Virus Load and Increase Dynamics after Lung Transplantation
por: Görzer, Irene, et al.
Publicado: (2015)

miRNAs Potentially Involved in Post Lung Transplant-Obliterative Bronchiolitis: The Role of miR-21-5p
por: Bozzini, Sara, et al.
Publicado: (2021)

Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis
por: Gross, Catharina C., et al.
Publicado: (2016)

The evolving role of alemtuzumab (Campath-1H) in renal transplantation
por: Pham, Phuong-Thu T, et al.
Publicado: (2009)

Human cytomegalovirus strain diversity and dynamics reveal the donor lung as a major contributor after transplantation
por: Külekci, Büsra, et al.
Publicado: (2022)

Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report
por: Okada, Naoki, et al.
Publicado: (2023)

Steroid Sparing Maintenance Immunosuppression in Highly Sensitised Patients Receiving Alemtuzumab Induction
por: Santos, Eva, et al.
Publicado: (2023)

Circulating miRNAs reflect early myocardial injury and recovery after heart transplantation
por: Wang, Enshi, et al.
Publicado: (2013)

Chest CT in patients after lung transplantation: A retrospective analysis to evaluate impact on image quality and radiation dose using spectral filtration tin-filtered imaging
por: Wressnegger, Alexander, et al.
Publicado: (2020)

Alemtuzumab for Multiple Sclerosis
por: Willis, Mark D., et al.
Publicado: (2016)

Alemtuzumab in Covid era
por: Iovino, Aniello, et al.
Publicado: (2021)

Follistatin-like 1 and Biomarkers of Neutrophil Activation Are Associated with Poor Short-Term Outcome after Lung Transplantation on VA-ECMO
por: Veraar, Cecilia, et al.
Publicado: (2022)

Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation
por: van der Zwan, Marieke, et al.
Publicado: (2017)

Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
por: Grasso, Margherita, et al.
Publicado: (2014)

Circulating miRNAs as biomarkers of kidney disease
por: Hüttenhofer, Alexander, et al.
Publicado: (2017)

Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
por: Duttagupta, Radha, et al.
Publicado: (2011)

Established and innovative surgical techniques for the treatment of benign subglottic stenosis
por: Evermann, Matthias, et al.
Publicado: (2020)

Alemtuzumab versus antithymocyte globulin induction therapies in kidney transplantation patients: A systematic review and meta-analysis of randomized controlled trials
por: Zheng, Jianming, et al.
Publicado: (2017)

Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases
por: Katoh, Masaru
Publicado: (2014)

MiRNAs as Novel Adipokines: Obesity-Related Circulating MiRNAs Influence Chemosensitivity in Cancer Patients
por: Withers, Sarah B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ukkdc4i12kvmfu2j09ic2kfimi